TVPW
ABBV icon

Third View Private Wealth’s AbbVie ABBV Stock Holding History

Third View Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.08M Buy
4,300
+1,249
+41% +$269K 0.13% 124
2026
Q1 		$664K Buy
3,051
+76
+3% +$16.9K 0.09% 145
2025
Q4 		$680K Buy
+2,975
New +$678K 0.09% 149

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Third View Private Wealth's ABBV Position: Q2 2026 in Review

Third View Private Wealth increased its AbbVie (ABBV) stake by 41% in Q2 2026, buying an estimated $269K and bringing the position to 4,300 shares worth $1.08M. The position accounts for 0.13% of the portfolio, ranked #124.

Third View Private Wealth first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Third View Private Wealth held 4,300 shares of AbbVie worth $1.08M as of Q2 2026.
  • Third View Private Wealth bought 1,249 AbbVie shares in Q2 2026, an estimated $269K.
  • AbbVie made up 0.13% of Third View Private Wealth's portfolio in Q2 2026, its #124 holding.
  • Third View Private Wealth first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Third View Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.